posting velocity //
Opens vs closes per day
Based on 0 events over 90 days. Green days had more opens than closes, red vice-versa. The dark line is the 7-day rolling average.
Posting timing (day/hour) is available only when there are at least 5 jobs with a real publish stamp spread across 3 distinct days. This company's source doesn't expose post times, or there isn't enough data yet — showing what we know for sure: how many jobs are open, in which domains, and at which seniority levels.
Showing: Israel. Click another pill to switch.
Open now
0
Total active openings across all sites
Δ 28-day
0
Opens minus closes in the last 28 days
Δ 90-day
0
Opens minus closes in the last 90 days
posting velocity //
Based on 0 events over 90 days. Green days had more opens than closes, red vice-versa. The dark line is the 7-day rolling average.
role mix //
—
The green layer is the current share of active openings by role. The grey dashed layer is the 90-day baseline — gaps between them show where the company is shifting its hiring mix.
seniority pyramid //
Seniority is not exposed by the source for this company.
Distribution of active openings by seniority. The 'unknown' row groups jobs from sources that don't expose seniority.
geography //
—
Active openings by region. Click a row to see jobs in that area.
time on market //
Median
—
25th pct
—
75th pct
—
—
Based on 0 closed jobs and 0 still open (right-censored). Curve is Kaplan-Meier; band is the 95% CI.
Window: 180 days back. Don't read the mean — the long tail biases it. Median and percentiles are the honest summary.
Republish rate
—
Fewer than 10 closures in the window — not enough to compute.
company intel · ai-generated
Updated 1d ago
Itamar Medical is an Israeli medtech company focused on the diagnosis and monitoring of sleep-disordered breathing, specifically obstructive sleep apnea. The company is listed on NASDAQ under the ticker ITMR. Its headquarters are in Caesarea, Israel, with significant commercial operations in the United States.
The flagship product is WatchPAT, a home sleep apnea test device based on PAT (Peripheral Arterial Tonometry) technology. The technology measures changes in peripheral arterial tone to detect apnea events, offering an alternative to full in-lab polysomnography. Primary buyers include physicians, sleep clinics, and insurers in the United States and Europe.
The WatchPAT family includes several variants: WatchPAT ONE, a disposable single-use home device, and the WatchPAT 300. The company also offers a software platform for managing and analyzing sleep study data alongside its hardware.
Itamar Medical's R&D and manufacturing center is based in Caesarea. Israel-based operations cover research, development, and manufacturing functions, while larger sales and marketing teams operate from the United States.
key people & leadership
1 key people, sourced from public records — with a per-row confidence score.
Gilad Glick
President and CEO
news feed
No recent news about this company.